MX2024007517A - Formas solidas de compuestos de pirazolo[3,4-d]pirimidina. - Google Patents

Formas solidas de compuestos de pirazolo[3,4-d]pirimidina.

Info

Publication number
MX2024007517A
MX2024007517A MX2024007517A MX2024007517A MX2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A MX 2024007517 A MX2024007517 A MX 2024007517A
Authority
MX
Mexico
Prior art keywords
pyrazolo
solid forms
pyrimidine compounds
pyrimidin
pyrrolidin
Prior art date
Application number
MX2024007517A
Other languages
English (en)
Spanish (es)
Inventor
Caroline Yvette Proulx-Lafrance
Erika Volckova
Jr John C Amedio
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2024007517A publication Critical patent/MX2024007517A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2024007517A 2021-12-16 2022-12-16 Formas solidas de compuestos de pirazolo[3,4-d]pirimidina. MX2024007517A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163290136P 2021-12-16 2021-12-16
PCT/US2022/081795 WO2023114995A1 (en) 2021-12-16 2022-12-16 Solid forms of pyrazolo[3,4-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
MX2024007517A true MX2024007517A (es) 2024-08-19

Family

ID=85172741

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024007517A MX2024007517A (es) 2021-12-16 2022-12-16 Formas solidas de compuestos de pirazolo[3,4-d]pirimidina.

Country Status (11)

Country Link
US (2) US12012412B2 (cg-RX-API-DMAC10.html)
EP (1) EP4448529A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024546844A (cg-RX-API-DMAC10.html)
KR (1) KR20240119299A (cg-RX-API-DMAC10.html)
CN (1) CN118401525A (cg-RX-API-DMAC10.html)
AU (2) AU2022416644B2 (cg-RX-API-DMAC10.html)
CA (1) CA3242577A1 (cg-RX-API-DMAC10.html)
IL (1) IL313314A (cg-RX-API-DMAC10.html)
MX (1) MX2024007517A (cg-RX-API-DMAC10.html)
TW (1) TW202333676A (cg-RX-API-DMAC10.html)
WO (1) WO2023114995A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024546844A (ja) 2021-12-16 2024-12-26 ファイザー・インク ピラゾロ[3,4-d]ピリミジン化合物の固体形態
WO2025043067A2 (en) * 2023-08-22 2025-02-27 Cardurion Pharmaceuticals, Inc. Pyrazolo[3,4-d]pyrimidinone compounds for the treatment of chronic heart failure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
PT2152712E (pt) 2007-05-11 2012-02-29 Pfizer Compostos amino-heterocíclicos
CN109893653A (zh) * 2017-12-11 2019-06-18 王慧敏 Pde9抑制剂的新用途
JP2024546844A (ja) * 2021-12-16 2024-12-26 ファイザー・インク ピラゾロ[3,4-d]ピリミジン化合物の固体形態

Also Published As

Publication number Publication date
CA3242577A1 (en) 2023-06-22
US12012412B2 (en) 2024-06-18
US20240300961A1 (en) 2024-09-12
TW202333676A (zh) 2023-09-01
JP2024546844A (ja) 2024-12-26
IL313314A (en) 2024-08-01
CN118401525A (zh) 2024-07-26
KR20240119299A (ko) 2024-08-06
AU2025275149A1 (en) 2026-01-08
WO2023114995A1 (en) 2023-06-22
EP4448529A1 (en) 2024-10-23
AU2022416644B2 (en) 2025-09-11
AU2022416644A1 (en) 2024-07-04
NZ812114A (en) 2025-08-29
US20230192707A1 (en) 2023-06-22

Similar Documents

Publication Publication Date Title
MX2021003241A (es) Sal de tosilato de pirrolo[2,3-d]pirimidina, forma cristalina de la misma y proceso de fabricacion e intermediario al mismo.
BRPI0314001B8 (pt) pirazolopirimidinas como inibidores de cinase dependente de ciclina e composição farmacêutica compreendendo as mesmas
ATE362474T1 (de) Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen
ATE470668T1 (de) Pyrazolopyrimidine als inhibitoren von cyclinabhängiger kinase zur behandlung von krebs
CA3242577A1 (en) Solid forms of pyrazolo[3,4-d]pyrimidine compounds
BR9609011A (pt) Composto
EP4745140A2 (en) PROCESS FOR RACEMIZING AND ISOLATING ATROPISOMERS OF 7-CHLORO-6-FLUORO-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D!PYRIMIDINE-2,4(1H,3H)-DIONE
RU2011116928A (ru) Гетероциклические ингибиторы jак киназы
MX2020009586A (es) Compuestos de (2-azabiciclo[3.1.0]hexan-2-il)pirazolo[1,5-a]pirimi dina e imidazo[1,2-b]piridazina sustituidos como inhibidores de cinasas trk.
TW200745128A (en) Pyrazolopyrimidines as protein kinase inhibitors
ECSP088345A (es) Nuevas pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina
MY137888A (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
MX385576B (es) Derivados de [1,2,4]triazol[1,5-a]pirimidina como inhibidores de pde2
WO2007044401A3 (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
UY37559A (es) Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton
WO2006069080A3 (en) Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
CY1110666T1 (el) Πυραζολοπυριμιδινες καταλληλες για θεραπεια καρκινικων νοσων
MX2020012636A (es) Formas de monohidrato y cristalinas de 6-[(3s,4s)-4-metil-1-(pirim idin-2- ilmetil)pirrolidin-3-il]-3-tetrahidropiran-4-il-7h-imidazo [1,5-a]pirazin-8- ona.
MX2019005123A (es) Compuestos de [1,2,4]triazolo[1,5-a]pirimidina como inhibidores de pde2.
WO2004106340A3 (en) 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF
GB2552269A (en) Substituted pyrrolo(2,3-D)pyrimidines for selectively targeting tumor cells with fr-alpha and fr-beta type receptors
ATE309246T1 (de) 1-(alkyl), 1-(heteroaryl)alkyl und 1-(aryl)alkyl)-7-(pyrimidin-4-yl)-imidazo(1,2-a pyrimidin-5(h)- one derivate
EA201990973A1 (ru) СОЕДИНЕНИЯ [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PDE2
KR960700246A (ko) 5-알콕시트리아졸로(1,5-C)피리미딘-2(3H)-티온화합물, 및 2,2-디티오비스트리아졸로-(1,5-C)-피리미딘) 및 2-클로로설포닐-5-알콕시트리아졸로(1,5-C)피리미딘 화합물의 제조에 있어서의 이의 용도(5-Alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione compounds and their use in the preparation of 2,2'-dithiobis(5-alkoxy[1,2,4]triazolo[1,5-c]-pyrimidine)and 2-chlorosufonyl-5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine compounds)
DE69930416D1 (de) Cgmp pde5 inhibitoren zur inhalationsbehandlung von sexueller dysfunktion